Welcome to our dedicated page for Steris Plc SEC filings (Ticker: STE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Steris鈥檚 infection-prevention empire across hospitals, pharma plants, and contract-sterilization sites means digging through dense regulatory text. Whether you need utilisation data on an ethylene-oxide facility or want to confirm how much the Life Sciences segment contributed last quarter, Steris SEC filings can feel overwhelming.
Stock Titan鈥檚 AI solves that problem. Our platform converts every Steris quarterly earnings report 10-Q filing and Steris annual report 10-K simplified into plain language, flags segment margin shifts, and highlights risk disclosures鈥�Steris SEC filings explained simply. AG真人官方-time alerts surface Steris Form 4 insider transactions the minute they hit EDGAR, so you can monitor Steris executive stock transactions Form 4 before the market reacts. Need context on sudden news? Our summaries of Steris 8-K material events explained link straight to affected business lines.
From Steris proxy statement executive compensation that details incentive metrics to Steris insider trading Form 4 transactions tracked against upcoming product launches, Stock Titan equips investors with:
- AI-powered bullet summaries for quick comprehension
- Form-level navigation covering 10-K, 10-Q, 8-K, S-1, 13D/G and more
- AG真人官方-time push alerts for Steris Form 4 insider transactions real-time
- Side-by-side earnings report filing analysis comparing sequential quarters
Stop combing through hundreds of pages alone鈥�understanding Steris SEC documents with AI means you get to the numbers, risks, and material changes faster, and make informed decisions with confidence.
STERIS plc (STE) filed a Form 144 reporting a proposed sale of 4,110 ordinary shares through Charles Schwab & Co., Inc., with an aggregate market value of $993,562.00 and an approximate sale date of 08/11/2025. The filing shows the securities were acquired on 08/11/2025 via an employee stock option exercise and the payment was made through a broker cashless exercise.
The table lists the issuer's shares outstanding as 98,490,606. The filing also states there were no securities sold in the past three months by the person for whose account these securities are to be sold and includes the standard attestation that the filer is not aware of undisclosed material adverse information.
STERIS plc filed a Form 144 reporting a proposed sale of 4,110 ordinary shares to be executed on 08/11/2025 through Charles Schwab & Co., Inc. The filing lists an aggregate market value of $994,450 and shows 98,490,606 shares outstanding. The shares were acquired on 08/11/2025 via an employee stock option exercise and the payment method is recorded as a broker payment for a cashless exercise.
The notice states no securities were sold by the person in the past three months and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
STERIS plc filed a Form 144 reporting a proposed sale of 3,495 ordinary shares with an aggregate market value of $844,249, to be sold on the NYSE through Charles Schwab on 08/11/2025. The shares were acquired on 08/11/2025 via an employee stock option exercise and payment was completed through a broker cashless exercise. The filing reports 98,490,606 shares outstanding and states Nothing to Report for securities sold in the past three months. The filing does not identify the person for whose account the securities are to be sold.
STERIS plc reported a Form 144 notice for an insider sale of ordinary shares. The filing shows 7,900 shares offered through Charles Schwab & Co., with an aggregate market value of $1,909,646.00 and 98,490,606 shares outstanding for the company. The shares were acquired and are to be sold on 08/11/2025 via an employee stock option exercise using a broker payment for a cashless exercise.
The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer. Relationship to the issuer and the identity of the selling person are not specified in the visible fields.
FAQ
What is the current stock price of Steris Plc (STE)?
What is the market cap of Steris Plc (STE)?
